BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Mariana Verdelho Machado, Helena Cortez-Pinto. Non-alcoholic fatty liver disease: What the clinician needs to knowWorld Journal of Gastroenterology 2014; 20(36): 12956-12980 doi: 10.3748/wjg.v20.i36.12956
2
Laurent Castera, Valérie Vilgrain, Paul Angulo. Noninvasive evaluation of NAFLDNature Reviews Gastroenterology & Hepatology 2013; 10(11): 666 doi: 10.1038/nrgastro.2013.175
3
Vitamin D Is Associated with Severity and Mortality of Non-alcoholic Fatty Liver Disease: A US Population-based StudyJournal of Clinical and Translational Hepatology  doi: 10.14218/JCTH.2017.00025
4
Long Wang, Mian Li, Zhiyun Zhao, Min Xu, Jieli Lu, Tiange Wang, Yuhong Chen, Shuangyuan Wang, Meng Dai, Yanan Hou, Xueyan Wu, Lina Ma, Lin Li, Shanshan Liu, Weiqing Wang, Yu Xu, Yufang Bi, Guang Ning. Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective AnalysisThe American Journal of Medicine 2018; 131(12): 1515.e1 doi: 10.1016/j.amjmed.2018.07.011
5
H. Perazzo, M. Munteanu, Y. Ngo, P. Lebray, N. Seurat, F. Rutka, M. Couteau, S. Jacqueminet, P. Giral, D. Monneret, F. Imbert-Bismut, V. Ratziu, A. Hartemann-Huertier, C. Housset, T. Poynard. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemiaAlimentary Pharmacology & Therapeutics 2014; 40(9): 1081 doi: 10.1111/apt.12946
6
Giorgio Sesti, Teresa Vanessa Fiorentino, Franco Arturi, Maria Perticone, Angela Sciacqua, Francesco Perticone, Claudia Miele. Association between Noninvasive Fibrosis Markers and Chronic Kidney Disease among Adults with Nonalcoholic Fatty Liver DiseasePLoS ONE 2014; 9(2): e88569 doi: 10.1371/journal.pone.0088569
7
Atilla Engin. Obesity and LipotoxicityAdvances in Experimental Medicine and Biology 2017; 960: 443 doi: 10.1007/978-3-319-48382-5_19
8
Karen L. Thomsen, Lionel Hebbard, Emilie Glavind, Andrew Clouston, Hendrik Vilstrup, Jacob George, Henning Grønbaek. Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in ratsLiver International 2014; 34(10): 1584 doi: 10.1111/liv.12547
9
Bo Kyung Koo, Donghee Kim, Sae Kyung Joo, Jung Ho Kim, Mee Soo Chang, Byeong Gwan Kim, Kook Lae Lee, Won Kim. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosisJournal of Hepatology 2017; 66(1): 123 doi: 10.1016/j.jhep.2016.08.019
10
Katharina Schwarzkopf, Joerg Bojunga, Sabrina Rüschenbaum, Yolanda Martinez, Marcus M. Mücke, Florian Seeger, Fabian Schoelzel, Stefan Zeuzem, Mireen Friedrich‐Rust, Christian M. Lange. Use of Antiplatelet Agents Is Inversely Associated With Liver Fibrosis in Patients With Cardiovascular DiseaseHepatology Communications 2018; 2(12): 1601 doi: 10.1002/hep4.1254
11
Sun Hwa Lee, Seong Jong Yun, Dong Hyeon Kim, Hyeon Hwan Jo, Yong Sung Park. Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart diseaseJournal of Clinical Ultrasound 2017; 45(7): 391 doi: 10.1002/jcu.22472
12
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher, Amedeo Lonardo. Clinical relevance of liver histopathology and different histological classifications of NASH in adultsExpert Review of Gastroenterology & Hepatology 2018; 12(4): 351 doi: 10.1080/17474124.2018.1415756
13
Marc–Emmanuel Dumas, James Kinross, Jeremy K. Nicholson. Metabolic Phenotyping and Systems Biology Approaches to Understanding Metabolic Syndrome and Fatty Liver DiseaseGastroenterology 2014; 146(1): 46 doi: 10.1053/j.gastro.2013.11.001
14
K.H. Williams, A.J. Viera de Ribeiro, E. Prakoso, A.S. Veillard, N.A. Shackel, Y. Bu, B. Brooks, E. Cavanagh, J. Raleigh, S.V. McLennan, G.W. McCaughan, W.W. Bachovchin, F.M. Keane, A. Zekry, S.M. Twigg, M.D. Gorrell. Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesityDiabetes Research and Clinical Practice 2015; 108(3): 466 doi: 10.1016/j.diabres.2015.02.024
15
Pegah Golabi, Maria Stepanova, Huong T Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, Zobair M Younossi. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)BMJ Open Gastroenterology 2018; 5(1): e000198 doi: 10.1136/bmjgast-2018-000198
16
Suzanne E. Mahady, Petra Macaskill, Jonathan C. Craig, Grace L.H. Wong, Winnie C.W. Chu, Henry L.Y. Chan, Jacob George, Vincent W.S. Wong. Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of FibrosisClinical Gastroenterology and Hepatology 2017; 15(9): 1453 doi: 10.1016/j.cgh.2017.02.031
17
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesWorld Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
18
Angelina Zhyvotovska, Denis Yusupov, Samy I. McFarlane. Dyslipidemia [Working Title]2019;  doi: 10.5772/intechopen.85094
19
Elif Dincses, Yusuf Yilmaz. Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(10): 1149 doi: 10.1097/MEG.0000000000000409
20
Daniel L. Motola, Peter Caravan, Raymond T. Chung, Bryan C. Fuchs. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future DirectionsCurrent Pathobiology Reports 2014; 2(4): 245 doi: 10.1007/s40139-014-0061-z
21
Changzhou Cai, Xin Song, Yishu Chen, Xueyang Chen, Chaohui Yu. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysisHepatology International 2019;  doi: 10.1007/s12072-019-09964-1
22
Hiroshi Ishiba, Yoshio Sumida, Seita Kataoka, Masaaki Kuroda, Satoshi Akabame, Kiichiro Tomiyasu, Muhei Tanaka, Masahiro Arai, Hiroyoshi Taketani, Yuya Seko, Akira Okajima, Tasuku Hara, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Yoshito Itoh. Association of coronary artery calcification with liver fibrosis in Japanese patients with non-alcoholic fatty liver diseaseHepatology Research 2016; 46(11): 1107 doi: 10.1111/hepr.12665
23
Wei-Jen Ting, Wei-Wen Kuo, Dennis Hsieh, Yu-Lan Yeh, Cecilia-Hsuan Day, Ya-Hui Chen, Ray-Jade Chen, Viswanadha Padma, Yi-Hsing Chen, Chih-Yang Huang. Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β SuppressionInternational Journal of Molecular Sciences 2015; 16(10): 25881 doi: 10.3390/ijms161025881
24
Zaki A. Sherif, Armana Saeed, Shima Ghavimi, Seyed-Mehdi Nouraie, Adeyinka O. Laiyemo, Hassan Brim, Hassan Ashktorab. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority PopulationsDigestive Diseases and Sciences 2016; 61(5): 1214 doi: 10.1007/s10620-016-4143-0
25
Trace Heavener, Ahmed Memon, Shamyal Khan, Sam Davis, Lauren Sager, Sharon DeMorrow, Mark Jeffries. Testing the ability of the nonalcoholic fatty liver disease fibrosis score to predict 1-year all-cause hospital admissionBaylor University Medical Center Proceedings 2019; 32(1): 26 doi: 10.1080/08998280.2018.1543227
26
Giorgio Sesti, Angela Sciacqua, Teresa Vanessa Fiorentino, Maria Perticone, Elena Succurro, Francesco Perticone, Anna Alisi. Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic SteatosisPLoS ONE 2014; 9(8): e104941 doi: 10.1371/journal.pone.0104941
27
Jun L. Chin, Michael Pavlides, Ahmad Moolla, John D. Ryan. Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00159
28
Tetsuya Takahashi, Tetsu Watanabe, Tetsuro Shishido, Ken Watanabe, Takayuki Sugai, Taku Toshima, Daisuke Kinoshita, Miyuki Yokoyama, Harutoshi Tamura, Satoshi Nishiyama, Takanori Arimoto, Hiroki Takahashi, Tamon Yamanaka, Takuya Miyamoto, Isao Kubota. The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failureHeart and Vessels 2018; 33(7): 733 doi: 10.1007/s00380-017-1113-1
29
Federico Salomone, Agnieszka Micek, Justyna Godos. Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-AnalysisJournal of Clinical Medicine 2018; 7(8): 219 doi: 10.3390/jcm7080219
30
Antonio De Vincentis, Luisa Costanzo, Umberto Vespasiani-Gentilucci, Antonio Picardi, Stefania Bandinelli, Luigi Ferrucci, Raffaele Antonelli Incalzi, Claudio Pedone. Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older peopleDigestive and Liver Disease 2019; 51(9): 1330 doi: 10.1016/j.dld.2019.01.017
31
Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 423 doi: 10.1007/978-3-030-11748-1_16
32
Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver DiseaseJournal of Clinical and Translational Hepatology  doi: 10.14218/JCTH.2017.00009
33
Serkan Dogan, Mehmet Celikbilek, Yunus K. Yilmaz, Savas Sarikaya, Gokmen Zararsiz, Halil I. Serin, Elif Borekci, Lütfi Akyol, Ilyas Pirti, Sena E. Davarci. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(3): 298 doi: 10.1097/MEG.0000000000000286
34
Lisa C. Adams, Falk Lübbe, Keno Bressem, Moritz Wagner, Bernd Hamm, Marcus R. Makowski, Pavel Strnad. Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control studyPLOS ONE 2018; 13(11): e0206450 doi: 10.1371/journal.pone.0206450
35
Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Per Stål, Rolf Hultcrantz, Stergios Kechagias. Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology 2019; 17(6): 1148 doi: 10.1016/j.cgh.2018.11.030
36
Meng-Hsuan Hsieh, Kuan-Ta Wu, Yi-Yu Chen, Jeng-Fu Yang, Wen-Yi Lin, Ning-Chia Chang, Chia-Yi Lin, Chao-Kuan Huang, Chao-Ling Wang, Hung-Yi Chuang, Shu-Ching Lin, Yu-Kuei Hsu, Yi-Shan Tsai, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai. Higher NAFLD fibrosis score is associated with impaired eGFRJournal of the Formosan Medical Association 2019;  doi: 10.1016/j.jfma.2019.07.007
37
Per Stål. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significanceWorld Journal of Gastroenterology 2015; 21(39): 11077-11087 doi: 10.3748/wjg.v21.i39.11077
38
Aynur Unalp-Arida, Constance E. Ruhl. Liver fibrosis scores predict liver disease mortality in the United States populationHepatology 2017; 66(1): 84 doi: 10.1002/hep.29113
39
Vlad Ratziu. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease2016; : 111 doi: 10.1002/9781118924938.ch13
40
Cory M. Fielding, Paul Angulo. Hepatic Steatosis and Steatohepatitis: Are they Really Two Distinct Entities?Current Hepatology Reports 2014; 13(2): 151 doi: 10.1007/s11901-014-0227-5
41
John B. Dixon. Surgical Management of Obesity in Patients with Morbid Obesity and Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2014; 18(1): 129 doi: 10.1016/j.cld.2013.09.011
42
Alessandra Gentili, Giulia Daviddi, Stefano De Vuono, Maria Anastasia Ricci, Francesco Di Filippo, Abdalkader Alaeddin, Massimo R. Mannarino, Marcello Boni, Gaetano Vaudo, Graziana Lupattelli. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patientsDigestive and Liver Disease 2016; 48(8): 904 doi: 10.1016/j.dld.2016.04.004
43
Zobair M. Younossi, Linda Henry. Noninvasive Scoring Systems for Persons With Chronic Liver Disease: Are They Ready for Prime Time?Gastroenterology 2019;  doi: 10.1053/j.gastro.2019.11.024
44
Veeravich Jaruvongvanich, Karn Wijarnpreecha, Patompong Ungprasert. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort studyClinics and Research in Hepatology and Gastroenterology 2017; 41(6): 629 doi: 10.1016/j.clinre.2017.03.010
45
M. Del Ben, L. Polimeni, F. Baratta, S. Bartimoccia, R. Carnevale, L. Loffredo, P. Pignatelli, F. Violi, F. Angelico. Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty LiverInternational Journal of Hepatology 2014; 2014: 1 doi: 10.1155/2014/784985
46
Guilherme M. Campos, David A. Lanning. Bariatric surgery for nonalcoholic fatty liver disease in adolescents with severe obesitySurgery for Obesity and Related Diseases 2015; 11(2): 449 doi: 10.1016/j.soard.2014.12.015
47
Evgin Goceri, Zarine K. Shah, Rick Layman, Xia Jiang, Metin N. Gurcan. Quantification of liver fat: A comprehensive reviewComputers in Biology and Medicine 2016; 71: 174 doi: 10.1016/j.compbiomed.2016.02.013
48
Zong Jie Koh, Hrishikesh Pandurang Salgaonkar, Wei Jie Jonathan Lee, Guo Wei Kim, Chun Hai Tan, Anton Cheng, Davide Lomanto, Jimmy Bok Yan So, Yock Young Dan, Asim Shabbir. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian CohortObesity Surgery 2019; 29(3): 862 doi: 10.1007/s11695-018-3581-5
49
Shanwen Charleen Yeo, Weijie Marc Ong, Kui Sing Anton Cheng, Chun Hai Tan. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis ScoreObesity Surgery 2019; 29(4): 1295 doi: 10.1007/s11695-018-03676-5